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Sir—We have read with great interest the study of the Finn-
ish Arthroplasty Register by Mäkelä et al. (2011) on patients 
under 55 years who had a primary total hip implant for pri-
mary osteoarthritis. This report is a follow-up of the previous 
report by Eskelinen et al. in Acta Orthop (2005). 
We agree with the authors that the population-based out-
comes of total hip arthroplasty appeared to be relatively 
unsatisfactory for younger patients in Finland. However, it is 
likely that the outcome for young patients with a total hip hip 
arthroplasty in Finland are even worse than the paper suggests. 
Unfortunately, and this remains unclear from the abstract, the 
current study of 3,668 primary hips is based on only 56% of 
all patients under 55 years who had a total hip implant in the 
research period in Finland for primary osteoarthritis. 
The researchers excluded 2,910 total hip arthroplasties, 
nearly all noncemented hip, because all noncemented 
implants with known poor track records as well noncemented 
implants not fitting in the cementless group 1 (implants with 
a cementless, straight, proximally circumferentially porous-
coated stem and a porous-coated press-fit cup) or 2 (implants 
with a cementless, anatomic, proximally circumferentially 
porous-coated stem, with or without hydroxyapatite, and a 
porous-coated press-fit cup with or without hydroxyapatite) 
were excluded, as well as those who had been implanted less 
than 10 times a year. They also excluded cemented total hips 
inserted with CMW or Boneloc cement, but these numbers 
are limited we guess. So, even after already excluding the 
implants with a poor outcome, the results were still somewhat 
disappointing and no better than cemented hips in the same 
population group in Finland. 
Despite the fact that we are now 5 years after the previ-
ous report of the Finnish register on this group of patients, 
there has been hardly any improvement on the outcome of 
noncemented hips in young patients. We had in 2005 and 
2006 some discussion with the Register on their interpreta-
tion based on the study in 2005 suggesting that for younger 
patients uncemented hips were most attractive (Schreurs et al. 
2005, 2006). 5 years later the outcome has not improved and 
even after a selection with exclosure of the poor performing 
implants, the conclusions remains the same. Looking at the 
data with revision for endpoint any reason, modern nonce-
mented hips are in Finland in young patients not superior to 
cemented hips. Certainly, wear is an important problem and 
companies have introduced many alternatives during the last 
years like large metal-on-metal head, newer polyethylene’s or 
ceramic on ceramic. However, one should not be too optimis-
tic that these innovations will solve the wear issue (Sedrakuan 
et al. 2011). 
The outcome of the Finnish register is in line with the con-
clusions of a literature study we just published on the outcome 
of total hips in patients under 50 years (de Kam et al. 2011). 
Although noncemented hips are widely used in patients under 
50 years, this trend remains unsupported by survival data. The 
most reliable results relate to cemented implants. The litera-
ture review was done up to 2009-01-01. 
Studies from hip registers do have major impact on ortho-
pedic practices, therefore these reports should be of the high-
est standard with an adequate overview of the literature. The 
authors suggest that several literature reports based on patients 
under 55 years do support the use of noncemented total hip 
arthroplasty and are fulfilling the NICE criteria, meaning a 
survival of more than 90% at a proven survival of 10 years 
after implantation with endpoint revision for any reason. 
However, the cited reports are incorrect. We previously had 
a discussion on the reports by Kim et al. 2002 and 2003 and 
McAuley et al. 2004 (Schreurs et al. 2005, 2006). Although 
these reports are approaching the NICE criterion, as we 
concluded in our discussion, they still are not updated for 
unknown reasons. This is remarkable as these reports could 
have been the first reports worldwide proving that the NICE 
criteria can be passed by noncemented hips in young patients. 
The suggestion that Pieringer et al. 2006, Reigstad et al. 2008, 
Garcia-Rey et al. 2009 and Anseth et al. 2010 are in favor of 
noncemented hip in patients under 55 years is incorrect. None 
of these papers is based on young patients under 55 years. The 
study of Delaunay et al. (2008) is also incorrect, they have a 
calculated and expected survival at 10 years probably fulfill-
ing the NICE criterion. However, the average follow-up of that 
series is 7.3 years, and it is known that between 7 and 10 years 
problems starting to occur. 
We are looking forward to the next update on this very inter-
esting study group of the Finnish arthroplasty register and are 
curious if their findings and conclusions will result in trends to 
use more proven implants. 
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Sir—We appreciate your interest in our article. Our aim was 
indeed to study modern cementless implants, not all the failed 
ones during the evolution of the cementless concept.
It is true that the clinical studies we referred to did not 
include exclusively patients under 55 years. The patient age in 
clinical studies we are familiar with is seldom limited to cer-
tain age groups. In register-based studies with high amount of 
patients like ours it is easier to define and analyze specific age 
groups, like patients under 55 years. In a clinical study from a 
single unit this is not so easy to do because of the small number 
of young patients. However, all the studies we referred to 
included patients under 55 years. We agree that optimally one 
should probably perform randomized, controlled arthroplasty 
trials in young patients.
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